Navigation Links
Red Nucleus Acquires R&D Software Solution

Red Nucleus Enterprises, LLC, (“Red Nucleus” or “RN”), a premier provider of learning, performance, and process solutions for the life sciences industry, has invested in Pyxa Systems (Pyxa), a research & development (R&D) focused software company offering process-enabled technology solutions for the global pharmaceutical industry. Pyxa’s flagship software product, DirectusPro, is a next-generation, structured content authoring, global label management, tracking, and reporting solution. DirectusPro ensures efficient information flow and compliance practices for global pharmaceutical label development, specifically the Core Data Sheet and Regional Product Information.

RN has two core lines of business: RN R&D and RN Commercial. Pyxa/DirectusPro will be part of RN’s R&D business. RN R&D delivers unrivaled capabilities for the life sciences industry. Its unique combination of cross-functional expertise, process-driven approach, and proven methodology increases compliance, reduces costs, and enhances overall efficiency for clients. RN’s R&D business offers a broad array of services pertaining to compliance with FDA/regulatory requirements throughout the drug lifecycle.

RN Commercial is the leading provider of learning solutions for the life sciences industry, taking traditional training approaches like print, e-learning, and workshops to a new level by marrying solid content and elegant design with the latest research-based adult learning methodologies and cutting-edge technology to help drive clients’ business objectives. RN’s Commercial business designs and develops training content that includes e-learning modules, mobile apps, virtual training, workshops, games, and printed materials primarily focused on the commercialization of pharmaceuticals.

Dalia El-Sherif, PhD, Red Nucleus R&D Strategy and Change Partner, commented, “RN currently offers end-to-end label process development and maintenance, label alignment, and drug listing and SPL management. DirectusPro will enable and enhance these services and activities.”

“We are thrilled about the addition of Pyxa and DirectusPro to the Red Nucleus family. There is strong overlap with Pyxa’s DirectusPro software and our existing R&D labeling services,” said Red Nucleus CEO Ian Kelly. “We are now able to offer our clients an industry game changer and strong foundation for R&D compliance software via DirectusPro and are excited to roll the product out to our clients.”

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. First location of melatonin in caudal spinal trigeminal nucleus
2. Degradation of viral DNA in the cell nucleus is opening up new treatment
3. Unchained Labs just cant get enough, acquires Avid Nano, rocks out the new pUNk!
4. Atheer Acquires ONtheGO Platforms to Further Advance Gesture Interaction with Augmented Reality Smart Glasses
5. UL Acquires InfoGard to Broaden Companys Range of Security Services
6. Rite Track Acquires Plus LLC
7. Spero Therapeutics Acquires Next Generation Antibacterial Candidates from Pro Bono Bio for Treatment of Multidrug-Resistant, Gram-Negative Infections
8. higi Raises Strategic Financing, Acquires EveryMove to Personalize Population Health
9. NREL research earns 3 prestigious R&D 100 Awards
10. VW tops global R&D ranking, but EU companies put in mixed performance
11. Life Sciences Discovery Fund announces R&D grants
Post Your Comments:
(Date:5/6/2020)... ... May 06, 2020 , ... ... ) will become the latest out-of-state company to partner with the device ... Brevitest has developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent ...
(Date:4/30/2020)... ... 28, 2020 , ... Pebble Labs USA Inc. , a biotechnology company ... with the mission of improving global food security, announced today that they have been ... in Food- and Ag-Tech ' virtual event, a global initiative to drive innovation in ...
(Date:4/26/2020)... (PRWEB) , ... April 23, 2020 , ... A team ... GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease ... and would be another potential treatment option for COVID-19. , The efforts are being ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... WILMINGTON, Del. (PRWEB) , ... May 12, 2020 ... ... selection of Interdisp JCS as the new distribution partner for all personal care ... the DuPont GENENCARE®OSMS portfolio and DuPont preservative portfolio for personal care. , ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of ... little or no information on the drug’s mechanism of action (MOA). Gene expression ... by measuring the activity of molecular pathways. This information can complement phenotypic readouts ...
(Date:5/5/2020)... PARIS (PRWEB) , ... May 05, 2020 , ... ... appointing a high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, ... Chemicals. , Holding a PhD in Immunology and being a Pharmacist, Xavier was involved ...
(Date:4/26/2020)... ... 2020 , ... Indegene Omnipresence, Inc. announced the launch of ... for use on Microsoft Azure. The customer experience management (CXM) technology allows life ... built-for-purpose customer engagement capability to use in their commercial or medical operations. ...
Breaking Biology Technology: